Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gupta, P.
Right arrow Articles by Verfaillie, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gupta, P.
Right arrow Articles by Verfaillie, C. M.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 95 No. 1 (January 1), 2000: pp. 147-155

Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins

Pankaj Gupta, Theodore R. Oegema Jr, Joseph J. Brazil, Arkaduisz Z. Dudek, Arne Slungaard, and Catherine M. Verfaillie

From the Departments of Medicine and Orthopædic Surgery and Biochemistry, Veterans Affairs Medical Center Minneapolis, MN, and University of Minnesota, Minneapolis, MN.

We have shown that stromal O-sulfated heparan sulfate glycosaminoglycans (O-S-GAGs) regulate primitive human hematopoietic progenitor cell (HPC) growth and differentiation by colocalizing heparin-binding cytokines and matrix proteins with HPC in stem cell "niches" in the marrow microenvironment. We now show that long-term culture-initiating cells (LTC-IC) are maintained for 5 weeks in the absence of stroma when O-S-GAGs are added to IL-3 and either MIP-1alpha or PF4 (LTC-IC maintenance without GAGs, 32 ± 2%; with GAGs, 95 ± 7%; P < .001). When cultured with 5 additional cytokines, O-S-GAGs, IL-3, and MIP-1alpha , LTC-IC expanded 2- to 4-fold at 2 weeks, and 92 ± 8% LTC-IC were maintained at 5 weeks. Similar results were seen when PF4 replaced MIP-1alpha . Although O-S-GAG omission did not affect 2-week expansion, only 20% LTC-IC were maintained for 5 weeks. When O-S-heparin was replaced by completely desulfated-, N-sulfated (O-desulfated), or unmodified heparins, LTC-IC maintenance at week 5 was not better than with cytokines alone. Unmodified- and O-S-heparin, but not desulfated- or N-sulfated heparin, bound to MIP-1alpha , IL-3, PF4, VEGF, thrombospondin, and fibronectin. However, the affinity of heparin for thrombospondin and PF4, and the association and dissociation rates of heparin for PF4, were higher than those of O-S-heparin. We conclude that (i) although cytokines may suffice to induce early expansion, adult human LTC-IC maintenance for longer than 1 month requires O-S-GAGs, and (ii) HPC support may depend not only on the ability of GAGs to bind proteins, but also on optimal affinity and kinetics of interactions that affect presentation of proteins in a biologically active manner to progenitors. (Blood. 2000;95:147-155)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Stem CellsHome page
X.-B. Zhang, J. L. Schwartz, R. K. Humphries, and H.-P. Kiem
Effects of HOXB4 Overexpression on Ex Vivo Expansion and Immortalization of Hematopoietic Cells from Different Species
Stem Cells, August 1, 2007; 25(8): 2074 - 2081.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Pan, M. S. Nelson, M. Reyes, L. Koodie, J. J. Brazil, E. J. Stephenson, R. C. Zhao, C. Peters, S. B. Selleck, S. E. Stringer, et al.
Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells
Blood, September 15, 2005; 106(6): 1956 - 1964.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
K. Harvey and E. Dzierzak
Cell-Cell Contact and Anatomical Compatibility in Stromal Cell-Mediated HSC Support During Development
Stem Cells, May 1, 2004; 22(3): 253 - 258.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. C. Mulloy, J. Cammenga, F. J. Berguido, K. Wu, P. Zhou, R. L. Comenzo, S. Jhanwar, M. A. S. Moore, and S. D. Nimer
Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element
Blood, December 15, 2003; 102(13): 4369 - 4376.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. Netelenbos, J. van den Born, F. L. Kessler, S. Zweegman, P. C. Huijgens, and A. M. Drager
In vitro model for hematopoietic progenitor cell homing reveals endothelial heparan sulfate proteoglycans as direct adhesive ligands
J. Leukoc. Biol., December 1, 2003; 74(6): 1035 - 1044.
[Abstract] [Full Text]


Home page
Stem CellsHome page
P. Denning-Kendall, S. Singha, B. Bradley, and J. Hows
Cobblestone Area-Forming Cells in Human Cord Blood Are Heterogeneous and Differ from Long-Term Culture-Initiating Cells
Stem Cells, November 1, 2003; 21(6): 694 - 701.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. D. Ho and M. Punzel
Hematopoietic stem cells: can old cells learn new tricks?
J. Leukoc. Biol., May 1, 2003; 73(5): 547 - 555.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. GOTTE
Syndecans in inflammation
FASEB J, April 1, 2003; 17(6): 575 - 591.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. E. Stringer, M. S. Nelson, and P. Gupta
Identification of an MIP-1alpha -binding heparan sulfate oligosaccharide that supports long-term in vitro maintenance of human LTC-ICs
Blood, March 15, 2003; 101(6): 2243 - 2245.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. Kadereit, L. S. Deeds, S. E. Haynesworth, O. N. Koc, M. M. Kozik, E. Szekely, K. Daum-Woods, G. W. Goetchius, P. Fu, L. A. Welniak, et al.
Expansion of LTC-ICs and Maintenance of p21 and BCL-2 Expression in Cord Blood CD34+/CD38- Early Progenitors Cultured over Human MSCs as a Feeder Layer
Stem Cells, November 1, 2002; 20(6): 573 - 582.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-P. Zanetta, R. Bindeus, G. Normand, V. Durier, P. Lagant, E. Maes, and G. Vergoten
Evidence for a Lectin Activity for Human Interleukin 3 and Modeling of Its Carbohydrate Recognition Domain
J. Biol. Chem., October 4, 2002; 277(41): 38764 - 38771.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. E. Stringer, M. J. Forster, B. Mulloy, C. R. Bishop, G. J. Graham, and J. T. Gallagher
Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha
Blood, August 13, 2002; 100(5): 1543 - 1550.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S.-I. Hung, A. C. Chang, I. Kato, and N.-C. A. Chang
Transient expression of Ym1, a heparin-binding lectin, during developmental hematopoiesis and inflammation
J. Leukoc. Biol., July 1, 2002; 72(1): 72 - 82.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020